NASDAQ:IVF INVO Fertility Q2 2026 Earnings Results & Report $2.70 +0.02 (+0.60%) As of 11:41 AM Eastern This is a fair market value price provided by Massive. Learn more. INVO Fertility reported Q2 2026 earnings on August 14, 2026. The company reported EPS of $5.60, while revenue was $2.18 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ2 2026Report DateAugust 14, 2026TimeAfter Market Closes INVO Fertility EPS ResultsActual EPS$5.60Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AINVO Fertility Revenue ResultsActual Revenue$2.18 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesSEC FilingEarnings HistoryCompany Profile INVO Fertility Q2 2026 Earnings FAQ Did INVO Fertility beat earnings estimates for Q2 2026? INVO Fertility (NASDAQ:IVF) reported earnings of $5.60 per share for Q2 2026. The report was announced on Friday, August 14, 2026. What was INVO Fertility's revenue for Q2 2026? INVO Fertility reported revenue of $2.18 million for Q2 2026. INVO Fertility Earnings HeadlinesINVO Fertility Partners with PatientFi to Help Make Fertility Treatment More AffordableNovember 5, 2026 | globenewswire.comINVO Fertility consensus price target raised 300% to $81.60November 2, 2026 | msn.comI'm handing you this stock todayElon doesn't own the chip inside his Teslas or Starlink dishes. He licenses it from one little known public company. Now he's planning 1,000,000 AI satellites in orbit, and every one could pay this company a royalty. Analyst Dylan says the window to get in closes around December 8th, before new money floods into the buildout.November 13 at 1:00 AM | Behind the Markets (Ad)INVO Fertility To Implement 1-for-4 Reverse Stock SplitOctober 28, 2026 | rttnews.comINVO Fertility, Inc. Announces 1-for-4 Reverse Stock Split Effective October 30, 2026October 27, 2026 | quiverquant.comQINVO Fertility Announces a 1:4 Reverse Stock Split Effective Pre-Market Opening on October 30, 2026October 27, 2026 | globenewswire.comSee More INVO Fertility Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like INVO Fertility? Sign up for Earnings360's daily newsletter to receive timely earnings updates on INVO Fertility and other key companies, straight to your email. Email Address About INVO FertilityINVO Fertility (NASDAQ:IVF). is a commercial-stage fertility company focused on expanding access to assisted reproductive technology. The company develops and commercializes fertility products and services designed to provide alternatives to conventional in vitro fertilization (IVF) treatment. Its principal product is INVOcell, a medical device used in the INVO Procedure. The system allows early-stage embryo incubation to take place inside the patient’s body rather than in a conventional laboratory incubator, while still involving the retrieval of eggs, fertilization, and subsequent embryo transfer under the supervision of fertility professionals. In addition to commercializing INVOcell, INVO Fertility operates and supports fertility centers that provide reproductive services, including IVF and related treatments. The company has pursued a clinic-based and partnership-oriented model intended to make fertility care available through lower-cost or more accessible treatment settings in the United States and select international markets. The company was formerly known as INVO Bioscience before adopting the INVO Fertility name.View INVO Fertility ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Costco's Record $30 Dividend Shows Just How Strong Its Cash Machine IsThese 3 Stocks Have Bought Back Billions, But Which Offers the Best Value?Hims & Hers Bounced Back 9%, But Its Earnings Reveal a Costly Trade-OffSix Flags Lost $366 Million in Q3—Its Insiders Just Went ShoppingGolden Dome’s $185 Billion Question: Who Actually Gets Paid?3 Pharmaceutical Stocks That Offer Safety and GrowthKeeping AI Cool: AAON Rides the AI Heatwave to Record Growth Upcoming Earnings Home Depot (11/17/2026)Walt Disney (11/17/2026)NVIDIA (11/17/2026)Lowe's Companies (11/18/2026)PDD (11/18/2026)TJX Companies (11/18/2026)Target (11/18/2026)Palo Alto Networks (11/18/2026)NetEase (11/19/2026)Alibaba Group (11/19/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
